The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo
Open accessAbstract
Recent studies indicate that IL-1α functions intracellularly in pathways independent of its cell surface receptors by translocating to the nucleus and regulating transcription. Similarly, the chromatin-associated protein HMGB1 acts as both a nuclear factor and a secreted proinflammatory cytokine. Here, we show that IL-33, an IL-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines, is an endothelium-derived, chromatin-associated nuclear factor with transcriptional repressor properties. We found that IL-33 is identical to NF-HEV, a nuclear factor preferentially expressed in high endothelial venules (HEV), that we previously characterized. Accordingly, in situ hybridization demonstrated that endothelial cells constitute a major source of IL-33 mRNA in chronically inflamed tissues from patients with rheumatoid arthritis and Crohn's disease. Immunostaining with three distinct antisera, directed against the N-terminal part and IL-1-like C-terminal domain, revealed that IL-33 is a heterochromatin-associated nuclear factor in HEV endothelial cells in vivo . Association of IL-33 with heterochromatin was also observed in human and mouse cells under living conditions. In addition, colocalization of IL-33 with mitotic chromatin was noted. Nuclear localization, heterochromatin-association, and targeting to mitotic chromosomes were all found to be mediated by an evolutionarily conserved homeodomain-like helix–turn–helix motif within the IL-33 N-terminal part. Finally, IL-33 was found to possess transcriptional repressor properties, associated with the homeodomain-like helix–turn–helix motif. Together, these data suggest that, similarly to IL1α and HMGB1, IL-33 is a dual function protein that may function as both a proinflammatory cytokine and an intracellular nuclear factor with transcriptional regulatory properties.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-33 is highly expressed within endothelial cells in the synovium of patients with rheumatoid arthritis87, and IL-33-deficient mice have reduced neutrophil migration in an experimental model of rheumatoid arthritis88, but the actual role of this cytokine in the pathogenesis of rheumatoid arthritis or other sterile inflammatory diseases remains to be determined.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [87]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biologic basis for interleukin-1 in disease.
Dinarello, C. (1996) · Blood · doi:10.1182/blood.v87.6.2095.bloodjournal8762095 · Cited by 4,344
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221
Schmitz, J., Owyang, A. M., Oldham, E. R., Song, Y., Murphy, E., McClanahan, T. K., Zurawski, G., Moshrefi, M., Qin, J., Li, X., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.09.015 · Cited by 3,773
HMG-1 as a Late Mediator of Endotoxin Lethality in Mice
Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L. V., et al. (1999) · Science · doi:10.1126/science.285.5425.248 · Cited by 3,386
Yang, Y., Li, S., Yang, Q., Shi, Y., Zheng, M., Liu, Y., Chen, F., Song, G., Xu, H., Wan, T., et al. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000358696 · Cited by 3,263
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
Lotze, M. T., & Tracey, K. J. (2005) · Nature reviews. Immunology · doi:10.1038/nri1594 · Cited by 2,490
Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion
Bonaldi, T., Talamo, F., Scaffidi, P., Ferrera, D., Porto, A., Bachi, A., Rubartelli, A., Agresti, A., & Bianchi, M. E. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg516 · Cited by 1,252
Association of transcriptionally silent genes with Ikaros complexes at centromeric heterochromatin.
Brown, K., Guest, S. S., Smale, S., Hahm, K., Merkenschlager, M., & Fisher, A. (1997) · Cell · doi:10.1016/s0092-8674(00)80472-9 · Cited by 824
HMG1 and 2, and related ‘architectural’ DNA-binding proteins
Thomas, J. O., & TRAVERS, A. A. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01801-1 · Cited by 619
Ikaros DNA-Binding Proteins Direct Formation of Chromatin Remodeling Complexes in Lymphocytes
Kim, J., Sif, S., Jones, B., Jackson, A., Koipally, J., Heller, E., Winandy, S., Viel, A., Sawyer, A., Ikeda, T., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80034-5 · Cited by 587
Research works printed but not linked: 1
- CA Dinarello Eur Cytokine Netw 11, 483–486 (2000).
Cited by
Sorted by citations
Items 601–700 of 965
Clerman, A., Noor, Z., Fishelevich, R., Lockatell, V., Hampton, B., Shah, N. G., Salcedo, M. V., Todd, N. W., Atamas, S. P., & Luzina, I. G. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.807636 · Cited by 22
Umebashi, K., Tokito, A., Yamamoto, M., & Jougasaki, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191659 · Cited by 22
Staurengo‐Ferrari, L., Trevelin, S. C., Fattori, V., Nascimento, D. C., de Lima, K. A., Pélayo, J. S., Figueiredo, F., Casagrande, R., Fukada, S. Y., Teixeira, M. M., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00962 · Cited by 22
Zhou, W., Zhang, J., Toki, S., Goleniewska, K., Johnson, M. O., Bloodworth, M. H., Newcomb, D. C., & Peebles, R. S. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1700605 · Cited by 23
Conti, P., Gallenga, C. E., Ronconi, G., Caraffa, A., & Kritas, S. K. (2019) · Dermatologic Therapy · doi:10.1111/dth.12943 · Cited by 22
The Functional Roles of IL-33/ST2 Axis in Ocular Diseases
Qian, Y., & Zhang, M. (2020) · Mediators of Inflammation · doi:10.1155/2020/5230716 · Cited by 22
IL33/ST2 Axis in Diabetic Kidney Disease: A Literature Review
Tonacci, A., Quattrocchi, P., & Gangemi, S. (2019) · Medicina · doi:10.3390/medicina55020050 · Cited by 23
Immune-mediated experimental arthritis in IL-33 deficient mice
Talabot‐Ayer, D., Martin, P., Seemayer, C. A., Vigne, S., Lamacchia, C., Finckh, A., Saïji, E., Gabay, C., & Palmer, G. (2014) · Cytokine · doi:10.1016/j.cyto.2014.05.007 · Cited by 25
Sterile inflammation – do innate lymphoid cell subsets play a role?
Russell, S. E. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00246 · Cited by 21
Rapid systemic surge of IL-33 after severe human trauma: a prospective observational study
Sundnes, O., Ottestad, W., Schjalm, C., Lundbäck, P., Poulsen, L. L. C., Mollnes, T. E., Haraldsen, G., & Eken, T. (2021) · Molecular Medicine · doi:10.1186/s10020-021-00288-1 · Cited by 21
Recent advances of eosinophils and its correlated diseases
Zhang, T., Zhu, H., Zhang, J., Huang, Z., Xiang, Z., & Hong, T. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.954721 · Cited by 23
Tsuji, G., Yamamura, K., Kawamura, K., Kido-Nakahara, M., Ito, T., & Nakahara, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914633 · Cited by 21
TCRVγ9 γδ T Cell Response to IL-33: A CD4 T Cell–Dependent Mechanism
Duault, C., Franchini, D., Familliades, J., Cayrol, C., Roga, S., Girard, J., Fournié, J., & Poupot, M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500260 · Cited by 22
Self-citationRole of IL-33 expression in oncogenesis and development of human hepatocellular carcinoma
Yang, Y. F., Wang, J., Li, Y., Zhao, Y., Wang, R., Wu, Q., Zheng, R., & Ou, Y. (2016) · Oncology Letters · doi:10.3892/ol.2016.4622 · Cited by 21
Epithelial Cell Regulation of Allergic Diseases
Gour, N., & Lajoie, S. (2016) · Current Allergy and Asthma Reports · doi:10.1007/s11882-016-0640-7 · Cited by 24
Group 2 ILC s: A way of enhancing immune protection against human helminths?
Nausch, N., & Mutapi, F. (2017) · Parasite Immunology · doi:10.1111/pim.12450 · Cited by 22
Interleukin-37: The Effect of Anti-Inflammatory Response in Human Coronary Artery Endothelial Cells
Yan, X., Xie, B., Wu, G., Hu, J., Wang, D., Cai, X., & Li, J. (2019) · Mediators of Inflammation · doi:10.1155/2019/2650590 · Cited by 21
Borghi, S. M., Mizokami, S. S., de Carvalho, T. T., Rasquel-Oliveira, F. S., Ferraz, C. R., Fattori, V., Hayashida, T. H., Peron, J. P. S., Camilios‐Neto, D., Ambrósio, S. R., et al. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.113980 · Cited by 21
The Paradigm Change of IL-33 in Vascular Biology
Demyanets, S., Stojković, S., Huber, K., & Wojta, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413288 · Cited by 23
Scanlon, S., & McKenzie, A. (2015) · Clinical and Experimental Allergy · doi:10.1111/cea.12464 · Cited by 23
Matrine exerts its neuroprotective effects by modulating multiple neuronal pathways
Chhabra, S., & Mehan, S. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01214-6 · Cited by 21
IL-33/ST2 Signaling in the Pathogenesis of Chronic Pain and Itch
Gao, T., Wang, C., Wang, Y., & Mi, W. (2023) · Neuroscience · doi:10.1016/j.neuroscience.2023.08.013 · Cited by 20
The physiological basis of intracrine stem cell regulation
Ré, R. N., & Cook, J. L. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00461.2008 · Cited by 20
Paranjape, A. R., Chernushevich, O., Qayum, A. A., Spence, A. J., Taruselli, M. T., Abebayehu, D., Barnstein, B. O., McLeod, J. J. A., Baker, B., Bajaj, G. S., et al. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a0316-125r · Cited by 20
Regulation of IL-33 by Oncostatin M in Mouse Lung Epithelial Cells
Richards, C. D., Izakelian, L., Dubey, A., Zhang, G. Y., Wong, S. C., Kwofie, K., Qureshi, A., & Botelho, F. M. (2016) · Mediators of Inflammation · doi:10.1155/2016/9858374 · Cited by 20
Finlay, C. M., Cunningham, K. T., Doyle, B., & Mills, K. H. G. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901321 · Cited by 22
Huard, A., Nam, H., Frank, A.-C., Sirait‐Fischer, E., Fuhrmann, D. C., Hofmann, M. C. J., Raue, R., Palmer, G., Brüne, B., de Bruin, N. M. W. J., et al. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2000923 · Cited by 21
Intracellular Function of Interleukin-1 Receptor Antagonist in Ischemic Cardiomyocytes
Vecile, E., Dobrina, A., Salloum, F. N., Tassell, B. W. V., Falcione, A., Gustini, E., Secchiero, S., Crovella, S., Sinagra, G., Finato, N., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053265 · Cited by 21
Fibroblasts and macrophages: Key players in the head and neck cancer microenvironment
Utispan, K., & Koontongkaew, S. (2016) · Journal of Oral Biosciences · doi:10.1016/j.job.2016.11.002 · Cited by 22
Hip Osteonecrosis Is Associated with Increased Plasma IL-33 Level
Ma, J., Guo, W., Li, Z., Wang, B., Li, S., & Wang, P. (2017) · Mediators of Inflammation · doi:10.1155/2017/1732638 · Cited by 20
Hasan, A., Kochumon, S., Al‐Ozairi, E., Tuomilehto, J., & Ahmad, R. (2019) · Disease Markers · doi:10.1155/2019/7901062 · Cited by 21
Role of TRPV1 and TRPA1 in TSLP production in nasal epithelial cells
Li, J., Wang, F., Meng, C., & Zhu, D. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111916 · Cited by 20
Innate-Type and Acquired-Type Allergy Regulated by IL-33
Yoshimoto, T., & Matsushita, K. (2014) · Allergology International · doi:10.2332/allergolint.13-ra-0657 · Cited by 20
The Role of Alarmins in Osteoarthritis Pathogenesis: HMGB1, S100B and IL-33
Palumbo, A., Atzeni, F., Murdaca, G., & Gangemi, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512143 · Cited by 20
Th2‐type innate immune responses mediated by natural helper cells
Koyasu, S., & Moro, K. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12106 · Cited by 20
Up-regulation of IL-33 expression in various types of murine cells by IL-3 and IL-4
Zhao, W., & Hu, Z. (2012) · Cytokine · doi:10.1016/j.cyto.2012.01.019 · Cited by 19
The Sterile Inflammation in the Exacerbation of HBV‐Associated Liver Injury
Yang, Q., Shi, Y., Yang, Y., Lou, G., & Chen, Z. (2015) · Mediators of Inflammation · doi:10.1155/2015/508681 · Cited by 21
IL‐33 broadens its repertoire to affect DC
Turnquist, H. R., & Thomson, A. W. (2009) · European Journal of Immunology · doi:10.1002/eji.200940026 · Cited by 19
Pérez, D. J., Patiño, E., & Orozco, J. (2021) · Electroanalysis · doi:10.1002/elan.202100237 · Cited by 18
Hofherr, A., Marin, E. L., Musiał, B., Seth, A., Slidel, T. W. F., Conway, J., Baker, D., Hansen, P., Challis, B., Bartesaghi, S., et al. (2024) · Kidney International Reports · doi:10.1016/j.ekir.2024.03.009 · Cited by 22
Identification and characterization of retinoic acid‐responsive genes in mouse kidney development
Takayama, M., Miyatake, K., & Nishida, E. (2014) · Genes to Cells · doi:10.1111/gtc.12163 · Cited by 18
Granulomas are a source of interleukin-33 expression in pulmonary and extrapulmonary sarcoidosis
Kempf, W., Zollinger, T., Sachs, M., Ullmer, E., Cathomas, G., Dirnhofer, S., & Mertz, K. D. (2014) · Human Pathology · doi:10.1016/j.humpath.2014.07.011 · Cited by 18
Inflammation in Human Disease: Anticytokine Therapy
Dinarello, C. A. (2009) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2008.11.006 · Cited by 18
Innate Lymphoid Cells: A Promising New Regulator in Fibrotic Diseases
Zhang, Y., Tang, J., Tian, Z., van Velkinburgh, J. C., Song, J. J., Wu, Y., & Ni, B. (2015) · International Reviews of Immunology · doi:10.3109/08830185.2015.1068304 · Cited by 18
The ST2/Interleukin-33 Axis in Hematologic Malignancies: The IL-33 Paradox
Allegra, A., Innao, V., Tartarisco, G., Pioggia, G., Casciaro, M., Musolino, C., & Gangemi, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205226 · Cited by 18
Application of proteomics in asthma research
Park, C., & Rhim, T. (2011) · Expert Review of Proteomics · doi:10.1586/epr.11.4 · Cited by 18
Lin, J., Liu, J., Ma, R., Hao, J., Liang, Y., Zhao, J., Zhang, A., Meng, H., & Lü, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.900826 · Cited by 18
Chen, L., Song, Z., Cao, X., Fan, M., Zhou, Y., & Zhang, G. (2022) · eLife · doi:10.7554/elife.75072 · Cited by 17
Furci, F., Murdaca, G., Allegra, A., Gammeri, L., Senna, G., & Gangemi, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314532 · Cited by 17
Wang, L., Li, H., Liang, F., Yi, H., Jiang, S., & Xiao, L. (2014) · Medical Oncology · doi:10.1007/s12032-014-0143-0 · Cited by 19
New Therapies of Neovascular AMD—Beyond Anti-VEGFs
Yerramothu, P. (2018) · Vision · doi:10.3390/vision2030031 · Cited by 21
Zhang, Y., He, J. G., Zheng, H., Huang, S., & Lü, F. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02264 · Cited by 18
Soluble ligands as drug targets for treatment of inflammatory bowel disease
Tong, X., Zheng, Y., Li, Y., Xiong, Y., & Chen, D. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107859 · Cited by 17
Involvement of IL-33 in the Pathophysiology of Systemic Lupus Erythematosus: Review
Sarrand, J., & Soyfoo, M. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063138 · Cited by 18
IL-33/ST2 immunobiology in coronary artery disease: A systematic review and meta-analysis
Liu, R., Liu, L., Wei, C., & Li, D. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.990007 · Cited by 17
Jensen, M. M., Jia, W., Schults, A. J., Ye, X., Prestwich, G. D., & Oottamasathien, S. (2018) · Cytokine · doi:10.1016/j.cyto.2018.05.012 · Cited by 18
Vyas, S., Srivastava, R. N., & Goswami, R. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03914-4 · Cited by 16
Dustin, C. M., Habibovic, A., Hristova, M., Schiffers, C., Morris, C. R., Lin, M.-C. J., Bauer, R. A., Heppner, D. E., Daphtary, N., Aliyeva, M., et al. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2000995 · Cited by 16
Chen, J., Xiao, P., Song, D., Song, D., Chen, Z., & Li, H. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1007450 · Cited by 16
Daghestani, M. H., Alqahtani, H. A., AlBakheet, A., Deery, M. A. A., Awartani, K. A., Daghestani, M. H., Kaya, N., WARSY, A., Coşkun, S., & Çolak, D. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11236941 · Cited by 16
Dai, X., Shiraishi, K., Muto, J., Mori, H., Murakami, M., & Sayama, K. (2023) · JID Innovations · doi:10.1016/j.xjidi.2023.100205 · Cited by 15
Interleukin-33: Friend or Foe in Gastrointestinal Tract Cancers?
Pisani, L. F., Teani, I., Vecchi, M. L., & Pastorelli, L. (2023) · Cells · doi:10.3390/cells12111481 · Cited by 19
Interleukin-33 and Behçet disease: Another cytokine among others
Hamzaoui, K., Bouali, E., & Hamzaoui, A. (2015) · Human Immunology · doi:10.1016/j.humimm.2015.03.011 · Cited by 16
Advances and Evolving Concepts in Allergic Asthma
Tung, H.-Y., Li, E., Landers, C. T., Nguyen, A., Kheradmand, F., Knight, J., & Corry, D. B. (2018) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0037-1607981 · Cited by 16
Luzina, I. G., Clerman, A., Fishelevich, R., Todd, N. W., Lockatell, V., & Atamas, S. P. (2019) · Cytokine · doi:10.1016/j.cyto.2019.02.015 · Cited by 16
The Contradictory Role of Interleukin-33 in Immune Cells and Tumor Immunity
Zhang, X., Chen, W., Zeng, P., Xu, J. X., & Diao, H. (2020) · Cancer Management and Research · doi:10.2147/cmar.s262745 · Cited by 17
DNA damage talks to inflammation
Cohen, I. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.11.002 · Cited by 16
Transcriptomic Regulation of Macrophages by Matrix-Bound Nanovesicle-Associated Interleukin-33
Cramer, M. C., Molina, C. P., Hussey, G. S., Turnquist, H. R., & Badylak, S. F. (2022) · Tissue Engineering Part A · doi:10.1089/ten.tea.2022.0006 · Cited by 15
Interleukin-33 regulates the functional state of microglia
Xiong, T., Wang, X., Zha, Y., & Wang, Y. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.1012968 · Cited by 18
Ji, C., Wang, X., Xue, B., Li, S., Li, J., Qiao, B., Du, J., Yin, M., & Wang, Y. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121958 · Cited by 15
Zhu, X., Lü, J., Rao, J., Ru, D., Gao, M., Shi, D., Cao, K., Wen, S., Dai, C., Wang, X., et al. (2023) · American Journal Of Pathology · doi:10.1016/j.ajpath.2023.05.002 · Cited by 15
Decoding the IL-33/ST2 Axis: Its Impact on the Immune Landscape of Breast Cancer
Stojanović, B., Gajović, N., Jurišević, M., Stojanovic, M. D., Jovanović, M., Jovanović, I., Stojanović, B., & Milošević, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814026 · Cited by 15
Cholinergic sensing of allergen exposure by airway epithelium promotes type 2 immunity in the lungs
Hayashi, R., Srisomboon, Y., Iijima, K., Maniak, P. J., Tei, R., Kobayashi, T., Matsunaga, M., Luo, H., Masuda, M. Y., O’Grady, S. M., et al. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2023.10.031 · Cited by 16
The effects of resiquimod in an ovalbumin-induced allergic rhinitis model
Qu, S., Qin, T., Li, M., Zhang, S., Ye, L., Wei, J., Fan, H., & Chen, B. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.04.015 · Cited by 15
Nagaoka, S., Yamada, D., Eguchi, H., Yokota, Y., Iwagami, Y., Asaoka, T., Noda, T., Kawamoto, K., Gotoh, K., Kobayashi, S., et al. (2020) · Cancer Science · doi:10.1111/cas.14709 · Cited by 13
Okragly, A. J., Corwin, K. B., Elia, M., He, D., Schroeder, O., Zhang, Q., Shiyanova, T. L., Bright, S. W., Dicker, S. B., Chlewicki, L. K., et al. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s320287 · Cited by 14
Preshaw, P. M., & Taylor, J. J. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0416-7.00021-4 · Cited by 15
Interesting effects of interleukins and immune cells on acute respiratory distress syndrome
Saki, N., Javan, M., Moghimian-Boroujeni, B., & Kast, R. (2023) · Clinical and Experimental Medicine (Testo stampato) · doi:10.1007/s10238-023-01118-w · Cited by 15
Dual function of IL-33 on proliferation of NIH-3T3 cells
Tominaga, S., Tago, K., Tsuda, H., & Komine, M. (2015) · Cytokine · doi:10.1016/j.cyto.2014.12.004 · Cited by 15
Zhao, X., Zhang, X., Lv, Y., Xu, Y., Li, M., Qingxia, P., Chu, Y., Liu, N., Zhang, G., & Zhu, L. D. (2016) · Immunology Letters · doi:10.1016/j.imlet.2016.08.007 · Cited by 15
Linking impaired skin barrier function to esophageal allergic inflammation via IL-33
Travers, J., Rochman, M., Miracle, C. E., Cohen, J. P., & Rothenberg, M. E. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.09.001 · Cited by 15
Sandig, H., Jobbings, C. E., Roldán, N. G., Whittingham‐Dowd, J., Orinska, Z., Takeuchi, O., Akira, S., & Bulfone‐Paus, S. (2013) · European Journal of Immunology · doi:10.1002/eji.201242786 · Cited by 15
Allergic Inflammation and Adipocytokines
Theoharides, T. C., Makris, M. P., & Kalogeromitros, D. C. (2008) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200802100101 · Cited by 15
IL-31/33 Axis in Atopic Dermatitis
Łacwik, J., Kraik, K., Laska, J., Tota, M., Sędek, Ł., & Gomułka, K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262010162 · Cited by 18
Chen, W., Li, L., Wu, Y., Yang, J., & Tzeng, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041544 · Cited by 14
Balaya, R. D. A., Subbannayya, Y., Modi, P. K., Palollathil, A., Gopalakrishnan, L., Bhandary, Y. P., Prasad, T. S. K., & Pinto, S. M. (2022) · Cells · doi:10.3390/cells11010138 · Cited by 14
Akimoto, M., Susa, T., Okudaira, N., Koshikawa, N., Hisaki, H., Iizuka, M., Okinaga, H., Takenaga, K., Okazaki, T., & Tamamori‐Adachi, M. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2218033120 · Cited by 14
Qian, F., He, R., Du, X., Wei, Y., Zhou, Z., Fan, J., & He, Y. (2024) · Neurochemical Research · doi:10.1007/s11064-024-04197-7 · Cited by 15
Expression of interleukin‐33 and its receptor ST 2 in periapical granulomas and radicular cysts
Velickovic, M., Pejnovic, N. N., Petrović, R., Mitrović, S., Jeftic, I. D., Kanjevac, T., & Lukić, A. (2015) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12312 · Cited by 14
Ohta, S., Tago, K., Funakoshi‐Tago, M., Matsugi, J., & Yanagisawa, K. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.04.013 · Cited by 14
IL-33 levels differentiate tuberculous pleurisy from malignant pleural effusions
Xuan, W., ZHANG, J.-C., Zhou, Q., Yang, W.-B., & MA, L.-J. (2014) · Oncology Letters · doi:10.3892/ol.2014.2109 · Cited by 14
Full Length Interleukin 33 Aggravates Radiation-Induced Skin Reaction
Kurow, O., Frey, B., Schuster, L., Schmitt, V., Adam, S., Hahn, M., Gilchrist, D. S., McInnes, I. B., Wirtz, S. J., Gaipl, U. S., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00722 · Cited by 16
Zhang, J., Chen, J., Mangat, S. C., Baruhupolage, C. P., Garrod, D. R., & Robinson, C. (2018) · Immunity Inflammation and Disease · doi:10.1002/iid3.216 · Cited by 14
New perspectives on IL-33 and IL-1 family cytokines as innate environmental sensors
Scott, I. C., Rees, D., & Cohen, E. S. (2018) · Biochemical Society Transactions · doi:10.1042/bst20170567 · Cited by 14
Kimura, Y., Hayashi, Y., Hitomi, S., Ikutame, D., Urata, K., Shibuta, I., Sakai, A., Ni, J., Iwata, K., Tonogi, M., et al. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.10.013 · Cited by 15
Tran, C. P., Scurr, M., O’Connor, L., Buzzelli, J. N., Ng, G. Z., Chin, S. C. N., Stamp, L. A., Minamoto, T., Giraud, A. S., Judd, L. M., et al. (2022) · Oncotarget · doi:10.18632/oncotarget.28238 · Cited by 14
Associations between interleukin and interleukin receptor gene polymorphisms and risk of gout
Liu, S., Zhou, Z., Wang, C., Guo, M., Chu, N., & Li, C. (2015) · Scientific Reports · doi:10.1038/srep13887 · Cited by 13
Meephansan, J., Subpayasarn, U., Ponnikorn, S., Chakkavittumrong, P., Juntongjin, P., Komine, M., Ohtsuki, M., & Poovorawan, Y. (2017) · The Journal of Dermatology · doi:10.1111/1346-8138.14009 · Cited by 13
Alt, C., Yuan, S., Wu, F., Stankovich, B. L., Calaoagan, J. M., Schopies, S., Wu, J. Y., Shen, J., Schneider, D., Zhu, Y., et al. (2019) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2019.05.030 · Cited by 13
Chung, Y.-H., Qian, Q., Huang, H.-Y., Chiu, W., Yang, C., & Tzeng, S. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.713336 · Cited by 13
Metadata
- Authors
- Carriere, V., Roussel, L., Ortega, N., Lacorre, D.-A., Americh, L., Aguilar, L., Bouche, G., & Girard, J.-P.
- Affiliations
- *Laboratoire de Biologie Vasculaire, Equipe Labellisée “La Ligue 2006,” Institut de Pharmacologie et de Biologie Structurale, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5089, 205 Route de Narbonne, 31077 Toulouse, France; and
- Centre National de la Recherche Scientifique (FR)
- Endocube, Prologue Biotech, BP700, Rue Pierre et Marie Curie, 31319 Labège Cedex, France
- Corresponding author
- Girard, Jean-Philippe
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2007-01-02
- Volume
- 104
- Issue
- 1
- Pages
- 282-287
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1765450
- OpenAlex
- W2093396768
- Cited by
- 966
- References
- 38
- Citations by year
- 2026: 20 · 2025: 29 · 2024: 30 · 2023: 49 · 2022: 50 · 2021: 51 · 2020: 47 · 2019: 51 · 2018: 58 · 2017: 55 · 2016: 64 · 2015: 70 · 2014: 52 · 2013: 56 · 2012: 72
- FWCI
- 12.14
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Association pour la Recherche sur le Cancer
- Drug Applied Research Center, Tabriz University of Medical Sciences
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- IL-33, ST2 receptor, heterochromatin, nuclear factors, transcriptional repressor, endothelial cells, high endothelial venules, rheumatoid arthritis, Crohn's disease, chronic inflammation, HMGB1
- MeSH terms
- Interleukin-33, Interleukin-1 Receptor-Like 1 Protein, Animals, Arthritis, Rheumatoid, Crohn Disease, HeLa Cells, Heterochromatin, Humans, Interleukins, Membrane Proteins, Mitosis, Nuclear Proteins, Receptors, Cell Surface, Repressor Proteins, RNA, Messenger, 3T3 Cells, Conserved Sequence, Receptors, Interleukin, Nuclear Localization Signals, Amino Acid Motifs, Endothelial Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review